Onyekachi Victor Onyedikachi

Onyekachi Victor Onyedikachi

Auto-generated profile, based on publicly available information

Onyekachi Victor Onyedikachi

University of Pittsburgh 1 Department of Immunology Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2024 in Bioinformatics Advances
Verified
Journal Article
Open access
VOVictor Omoboyede
Victor Omoboyede
NONwachukwu Christiana Okonkwo
Nwachukwu Christiana Okonkwo
JBJimoh Olayemi Balogun
Jimoh Olayemi Balogun
OOOnyekachi Victor Onyedikachi
Onyekachi Victor Onyedikachi
RORita Ononiwu
Rita Ononiwu
PCprosper Obed chukwuemeka
prosper Obed chukwuemeka
Motivation: Cervical cancer remains a leading cause of gynecological mortality, with existing treatments often limited by resistance and suboptimal efficacy. While Coffea arabica is rich in phytochemicals with reported anticancer properties, their relevance to cervical cancer-specific molecular targets remains underexplored. Here, we integrated transcriptomic profiling, cheminformatics, and survival modeling to evaluate the therapeutic potential of C. arabica compounds in cervical cancer. Results: From 158 bioactive compounds with favorable pharmacokinetic and drug-likeness properties, we predicted gene targets and intersected them with 1779 differentially expressed genes identified from bulk RNA-sequencing of 304 cervical cancer tumors and 47 normal cervical tissues. This yielded 43 C. arabica gene targets that were significantly dysregulated in cervical cancer. Pathway enrichment revealed involvement in tumorigenesis, immune modulation, and cell cycle regulation, with fold enrichment computed as the ratio of observed-to-expected gene overlap. Survival analysis identified 14 of these genes as markers of poor prognosis, with matrix metalloproteinase-7 (MMP7) emerging as an independent prognostic marker of adverse outcome. A Random-Forest-Regression model trained on 499 experimentally validated MMP7 inhibitors identified carnosol—a C. arabica compound—as a top-ranking candidate with high predicted activity. These findings nominate carnosol as a promising therapeutic lead for cervical cancer and lay the groundwork for future experimental validation. Availability and implementation: The data supporting the findings of this study, including bulk RNA-seq gene expression data, survival, and phenotype data, are available through the TCGA database. These data can be accessed via the Xenabrowser platform (https://xenabrowser.net) using the reference identifier [TCGA Cervical Cancer (CESC)]. Corresponding healthy cervical tissue RNA-seq data, are available through the Genotype-Tissue Expression (GTEx) project (https://www.gtexportal.org/home/). The codes used for differential gene expression (DGE) analysis, pathway enrichment, and survival analysis, as well as scripts for generating volcano plots (DGE analysis), Kaplan-Meier survival plots, and boxplots (gene expression), and machine learning implementations are available on GitHub (https://github.com/Ponaskillzyy/Coffea_arabica_Potential_in_Cervical_Cancer).

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
Volcano plot of differential gene expression in WT and Tim-3 KO tumor Treg.

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
CD8 T cells are required for the anti-tumor response in Treg-specific Tim-3 KO mice.

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
No effect of delayed Tim-3Treg KO on proportions of CD8 T cells in TIL or dLN.

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
Relationship between the expression of Tim-3 and selected cell-surface proteins on TIL Treg.

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
Compromised activation and survival of Tim-3 KO Treg cultured in vitro.